Morbidity and Mortality Weekly Report (MMWR)

MMWR erratum volume 71, number 10.

This report describes adult COVID-19 hospitalization rates by race/ethnicity during SARS-CoV-2 Delta and Omicron predominance.

This report describes effectiveness of mRNA COVID-19 vaccination in preventing COVID-19 associated invasive mechanical ventilation and death after receiving 2 or 3 vaccine doses.

This report describes tobacco use by U.S. adults from 2019 to 2020.

This report describes the rate of unintentional traumatic brain injury deaths in persons 19 and younger.

This report describes the Advisory Committee on Immunization Practices’ recommendation for use of the Moderna COVID-19 vaccine in adults.

This report describes the number of end-stage kidney disease cases in the United States.

This report describes progress toward elimination of maternal and neonatal tetanus.

This report describes COVID-19 hospitalization rates among infants and children aged 0-4 years, including during Omicron variant predominance.

This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents.

This report describes the percentage of adults who sleep less than seven hours on average.

This report describes a case of congenital varicella syndrome in Illinois.

This report describes COVID-19 vaccine provider access and vaccination coverage among U.S. children aged 5–11 years.

This report describes the effect of COVID-19 on serological assays associated with dengue or Zika Virus.

This report describes the treatment of Chagas disease using nifurtimox.

This report describes the effectiveness of the influenza vaccine during the 2021-2022 flu season.

This report compares COVID-19 incidence in Arkansas K–12 school districts between those with mask requirements versus those without mask requirements.

This report describes the percentage of adults with kidney disease in the United States

This report describes initial reports of hantavirus infection in District of Columbia during 2018.

This report describes COVID-19 vaccination coverage between rural and urban counties.

This report describes an analysis of HIV infection data collected during surveillance in Malawi.

This report describes use of type 2 oral poliovirus vaccine to treat a poliovirus outbreak in Tajikistan.

This report describes mRNA COVID-19 vaccine effectiveness in preventing emergency department and urgent care encounters as well as hospitalizations among children and adolescents.

This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.

This report describes how Omicron infection resulted in high transmission among household contacts. Prevention strategies are important to reduce transmission in households.

This report describes a recommendation for using a 4-month regimen for the treatment of drug-susceptible pulmonary tuberculosis.

This report describes updated guidance on use of the Ebola vaccine.

This report describes age-adjusted suicide rates for males and females in the U.S.

MMWR erratum volume 71, number 3.

This report describes the NFL’s test-to-release COVID-19 mitigation strategy.

This report describes changes in U.S. suicide rates from 2019 to 2020.

This report describes the percentage of positive antigen test results following COVID-19 isolation.

This report describes increases in emergency department visits for mental health conditions among adolescent females in 2020, 2021, and 2022.

This report describes how overall pediatric emergency department visits decreased in 2020, 2021, and January 2022 compared with 2019 but COVID-19 visits predominated.

This report describes changes in the 2022 child and adolescent immunization schedule.

This report describes an outbreak of the SARS-CoV-2 Omicron variant among people attending a convention in New York City.

This report describes SARS-CoV-2 transmission at a large indoor convention among a highly vaccinated population.

CDC reports on assisted reproductive technology procedures performed in 2018.

This report describes an outbreak of Delta variant aboard a U.S. Navy ship.

This report describes death rates attributed to excessive cold or hypothermia.

This report describes increases in COVID-19 hospitalization rates among children and adolescents during Omicron, especially among children not yet eligible for vaccination.

This report describes maternal mRNA vaccine effectiveness against COVID-19 hospitalizations among infants under 6 months of age.

This report describes how local and systemic reactions and myocarditis are less frequent after a homologous COVID-19 booster dose.

This report describes how vaccine effectiveness against COVID-19–associated emergency department/urgent care visits and hospitalizations was higher after the third dose but decreased with time.

This report describes dental care rates among children with and without heart conditions.

This report describes antibiotic prescribing rates in a peer comparison.

This report describes genomic surveillance sequencing of COVID-19 variants by jurisdiction.

This report describes tiredness among children and adolescents by age and screentime.

This report describes global progress towards rubella elimination.

This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.